{"id":924239,"date":"2026-01-06T12:56:34","date_gmt":"2026-01-06T17:56:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/"},"modified":"2026-01-06T12:56:34","modified_gmt":"2026-01-06T17:56:34","slug":"fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/","title":{"rendered":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">HOUSTON, Jan.  06, 2026  (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O\u2019Heeron, will present at the 9<sup>th<\/sup> Annual BFC Global Healthcare Business Development and Investment Conference taking place January 11, 2026, at The St. Regis in San Francisco, California.<\/p>\n<p align=\"justify\">FibroBiologics will deliver a company presentation at 4:30 p.m. PT on Sunday, January 11.<\/p>\n<p>For more information, please visit FibroBiologics&#8217;\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mp6v1InEjvAHBzxb9z3V2x-UxGbUGJaxJM66ru7f3_OxBy7QE4h2UdStRB3hTu4vFz0kPQFwZrAiyUzkq8KLavc_DKjtnNcTM-seZrwJMTDJPQnd9q4h9nNIGzNWEcxqzPDoKI8Jc5sqoEV4_1aOjQWFFHT1qlCxBAWAYlxxjiUWN6J0PRYf0DVvDzF5brvqfCqOPzYxPL688sPfoeNVexrTZ_npMhz_oO50tW_OakI=\" rel=\"nofollow\" target=\"_blank\">website<\/a>\u00a0or email FibroBiologics at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B7Rw2-nVQxq9eDhPMoG1oyQRERu8M-EIDxkF-dyWIDbnrPPPDep25K9b0d39zkT_Ua6IiaJAWW8HyygMc-noy3eQ9mn-3W6vxmyOPVDe8_5XxFAcMwujusiBUsIby2DMGHkK2Y4i_XPkf8AktVjAzao3MXuowezc65qCHz_nFPDf9a322GbSonXshwDcgh1Pp0NkhICkUOvE595kSgw3JpKNx1jDbrhda81knFvbl5mJkpTHPLBxZO13ar0LS6C_eXcsfe_C5EThKA1bWFYz7Q==\" rel=\"nofollow\" target=\"_blank\">info@fibrobiologics.com<\/a>.<\/p>\n<p>\n        <strong>About FibroBiologics<\/strong>\n      <\/p>\n<p>Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents\/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1Xs-ViR9zF5f6eQFxL7Eeavo6yhhnzbzxSFayIKLxaPsBkK79fmZ7fmiEzkzzTxnKvkIBFOLP8yUm1vvjb3swNPnd8k8f7iUoNUz3tDnS5Y=\" rel=\"nofollow\" target=\"_blank\">www.FibroBiologics.com<\/a>.<\/p>\n<p>\n        <strong>General Inquiries:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B7Rw2-nVQxq9eDhPMoG1oyQRERu8M-EIDxkF-dyWIDbEo8lXpQXqOOv4JwUJt4X2-lpZZ4PZIW3f-iAGpwp-7gIfx0F01TjRrPsGMjSTFvQ=\" rel=\"nofollow\" target=\"_blank\">info@fibrobiologics.com<\/a>\n      <\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>Nic Johnson<br \/>Russo Partners<br \/>(212) 845-4242<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VlNGTbHi9wcztHA34mSGWC4ZIwgz0OhYOLWwrecOSL6qY-kk_FWd9-lmzj5OBmK-GYrlg2oVjwWkHsdOak5OiRK3DmvwXa-QqqpNEK6kD-Ef14KbDCFLHEYrS-pGGoYL\" rel=\"nofollow\" target=\"_blank\">fibrobiologicsIR@russopr.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Liz Phillips<br \/>Russo Partners<br \/>(347) 956-7697<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O16gMwz0ydt4BtXcj3Z8FmtmS2nCWIREVvnDhGrcE1g8lw7GqYBgk0r_y4uT8XlaREqT5Fw3DXFyrFOygfOCvJlI-zz8EtiIaU95Wl28ZoZJnc-tCJ8RHqSf7dCeNi2T8Ud3DjCu2r4garL3-EHMxLKBf6NEhp9YGuSyQ80-IponfxhEXq6FXDld2fL0ovjtpxMF0X-Xu-Mi9YRB-8OA60_Jmu2MFzGw0wnr8bZ0Tkj--_8qeX07OF8Q8uOOCj2Nx5Q7zme9rBwGWhXS5DqyBFLcw9oqpagouophs06TDvV1FeYATBcNcid_c3HUaRRxZmkI6cPHehdlldeAb7-Q8vKG819LOLms63tkIlPQRVxG0pVMlmsILXEnjbWCNP3Z\" rel=\"nofollow\" target=\"_blank\">Elizabeth.phillips@russopartnersllc.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTA2NWI5ZDEtZDgyNS00ODAxLTllODEtOGZlOWI2MmQ0MTllLTEyNzUwODEtMjAyNi0wMS0wNi1lbg==\/tiny\/FibroBiologics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O\u2019Heeron, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference taking place January 11, 2026, at The St. Regis in San Francisco, California. FibroBiologics will deliver a company presentation at 4:30 p.m. PT on Sunday, January 11. For more information, please visit FibroBiologics&#8217;\u00a0website\u00a0or email FibroBiologics at:\u00a0info@fibrobiologics.com. About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-924239","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O\u2019Heeron, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference taking place January 11, 2026, at The St. Regis in San Francisco, California. FibroBiologics will deliver a company presentation at 4:30 p.m. PT on Sunday, January 11. For more information, please visit FibroBiologics&#8217;\u00a0website\u00a0or email FibroBiologics at:\u00a0info@fibrobiologics.com. About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments &hellip; Continue reading &quot;FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-06T17:56:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference\",\"datePublished\":\"2026-01-06T17:56:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/\"},\"wordCount\":218,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/\",\"name\":\"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\",\"datePublished\":\"2026-01-06T17:56:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk","og_description":"HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O\u2019Heeron, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference taking place January 11, 2026, at The St. Regis in San Francisco, California. FibroBiologics will deliver a company presentation at 4:30 p.m. PT on Sunday, January 11. For more information, please visit FibroBiologics&#8217;\u00a0website\u00a0or email FibroBiologics at:\u00a0info@fibrobiologics.com. About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments &hellip; Continue reading \"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-06T17:56:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference","datePublished":"2026-01-06T17:56:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/"},"wordCount":218,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/","name":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=","datePublished":"2026-01-06T17:56:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMDMyNSM3MzQ1ODYwIzIyNjM1MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-to-present-at-9th-annual-bfc-global-healthcare-business-development-and-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/924239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=924239"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/924239\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=924239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=924239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=924239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}